Levinthal’s Paradox asks how a protein with 10^47 permutations finds the right fold in under a second. The answer is simple: it follows a landscape. Peptide therapeutics must navigate an even higher combinatorial space.

We’re live. Ormoni Biosciences is industrializing peptide drug development: 30-day make-test-learn cycles, thousands of peptides per animal experiment, driving proprietary peptide PK/PD ML models. The result is a platform that generates DC-quality molecules in months.